Market revenue in 2021 | USD 48.9 million |
Market revenue in 2028 | USD 87.4 million |
Growth rate | 8.6% (CAGR from 2021 to 2028) |
Largest segment | Left ventricular assist devices |
Fastest growing segment | Total Artificial Heart (TAH) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Left ventricular assist devices, Right ventricular assist devices, Bi-ventricular assist devices, Total Artificial Heart (TAH) |
Key market players worldwide | Johnson & Johnson, Medtronic PLC, Abbott Laboratories, Cardio Diagnostics Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ventricular assist device market will help companies and investors design strategic landscapes.
Left ventricular assist devices was the largest segment with a revenue share of 83.84% in 2021. Horizon Databook has segmented the Japan ventricular assist device market based on left ventricular assist devices, right ventricular assist devices, bi-ventricular assist devices, total artificial heart (tah) covering the revenue growth of each sub-segment from 2018 to 2028.
Japan is a highly developed country in Asia Pacific, mainly due to technological advancements in electronics, information technology, and others. In terms of healthcare indicators, Japan has greater than 25.0% aging population, i.e., people aged 65 or above, increasing healthcare GDP and technologically advanced medical devices are few of the other factors responsible for growth of VADs in Japan over the forecast period.
As per World Bank healthcare expenditure as total (% of GDP) estimates, nearly 10.9% of GDP was spent on healthcare. However, prevalence of Chronic Heart Failure (CHF) is low as compared to the other developed nations.
Moreover, growing prevalence of heart failure in Japan owing to growing geriatric population, increasing life expectancy, westernized dietary habits, obesity, and sedentary lifestyle is expected to boost ventricular assist device market across Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan ventricular assist device market , including forecasts for subscribers. This country databook contains high-level insights into Japan ventricular assist device market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account